Recipharm AB:企業のM&A・事業提携・投資動向

◆英語タイトル:Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2027
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:144
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Recipharm AB – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Recipharm AB since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Recipharm AB’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Recipharm AB. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Recipharm AB’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Recipharm AB and its subsidiaries since 2007.
- Information about key financial and legal advisors for Recipharm AB’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Recipharm AB’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 104
Partnership – Overview 104
Partnership – Deal reports 105
CAPITAL RAISING 119
Capital Raising – Overview 119
Capital Raising – Deal reports 120
DIVESTMENTS 124
Divestments – Overview 124
Divestments – Deal reports 125
PRIVATE EQUITY & OWNERSHIP 133
Private Equity and Ownership – Deal reports 133
APPENDIX 134
Contact Us 134
About MarketLine Financial Deals Database 134
Deal Definition and Methodology 136
About MarketLine 143

List of Tables
Table 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Table 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Table 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Table 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Table 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Table 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Table 7: Recipharm AB divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Figure 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Figure 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Figure 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Figure 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Figure 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Figure 7: Recipharm AB divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Recipharm AB:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab seque …
  • Development Bank of Southern Africa:企業の戦略的SWOT分析
    Development Bank of Southern Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Even Construtora E Incorporadora Sa
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • DS Smith Plc:企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Lloyd’s of London:企業の戦略・SWOT・財務情報
    Lloyd's of London - Strategy, SWOT and Corporate Finance Report Summary Lloyd's of London - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dometic Group AB:企業の戦略・SWOT・財務情報
    Dometic Group AB - Strategy, SWOT and Corporate Finance Report Summary Dometic Group AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sobeys Inc:戦略・SWOT・企業財務分析
    Sobeys Inc - Strategy, SWOT and Corporate Finance Report Summary Sobeys Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • National Stock Exchange of India Ltd.:企業のM&A・事業提携・投資動向
    National Stock Exchange of India Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Stock Exchange of India Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Comerica Incorporated:企業の戦略・SWOT・財務情報
    Comerica Incorporated - Strategy, SWOT and Corporate Finance Report Summary Comerica Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Immucor, Inc.-医療機器分野:企業M&A・提携分析
    Summary Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to …
  • Naturex SA:企業の戦略・SWOT・財務情報
    Naturex SA - Strategy, SWOT and Corporate Finance Report Summary Naturex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Oglethorpe Power Corporation
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Whiting Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rock …
  • J. Knipper and Company Inc:企業の戦略的SWOT分析
    J. Knipper and Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Gold Fields Ltd:戦略・SWOT・企業財務分析
    Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • University of Texas Health Science Center at San Antonio-医療機器分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Danone SA:企業の戦略・SWOT・財務情報
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆